Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

13 Canadian Crypto ETFs (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Mark These Tax-loss Selling Dates on Your Calendar (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

Can You Invest in Elon Musk’s Neuralink? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Investing in Graphene Companies (Updated 2024)

Trending Press Releases

US$30 Million Prepayment Term Sheet and Offtake Agreement Executed with a Global Commodities Trader

Spearmint More Than Doubles the Acreage of the George Lake South Antimony Project in New Brunswick, Canada

Radiopharm achieves Nasdaq listing of ADS

First Helium Licenses First of Two Wells Targeting Leduc Light Oil at Worsley

COLDry Fertiliser JV Seed Funding & Working Capital Secured

Mawson Finland Limited Identifies Compelling Soil Geochemical Targets for Follow-Up

More Press Releases
Trending Companies

First Helium

HELI:CA

Purpose Bitcoin ETF

BTCC:CA

Black Swan Graphene

SWAN:CC

Soma Gold Corp.

SOMA:CA
More Companies
Trending Reports

2025 Gold Outlook Report

2025 Crypto Outlook Report

2025 Gold Outlook: Australia Edition

2025 Uranium Outlook

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Fennec Pharmaceuticals Inc.

TSX:FRX
Press Releases

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children.

Interactive Chart

×